COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 2449: Articles 24481-24490  | Next

Comparisons of the genome of SARS-CoV-2 and those of other betacoronaviruses
Rodriguez-Roman, E., Gibbs, A. J.
10.1101/2020.07.12.199521 — Posted: 2020-07-13
Modulating the transcriptional landscape of SARS-CoV-2 as an effective method for developing antiviral compounds
Hoagland, D. A., Clarke, D. J. B., Moeller, R., Han, Y., Yang, L., Wojciechowicz, M. L., Lachmann, A., Oguntuyo, K. Y., Stevens, C., Lee, B., Chen, S., Ma'ayan, A., tenOever, B. R.
10.1101/2020.07.12.199687 — Posted: 2020-07-13
Single-cell analysis reveals the function of lung progenitor cells in COVID-19 patients
Zuo, W., Zhao, Z., Zhao, Y., Zhou, Y., Wang, X., Zhang, T.
10.1101/2020.07.13.200188 — Posted: 2020-07-13
PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2.
Theise, N. D., Arment, A. R., Chakravarty, D., Gregg, J. M. H., Jacobson, I. M., Jung, K. H., Nair, S. S., Tiwari, A., Thurston, A. W., Van Drie, J., Westover, J. B.
10.1101/2020.07.12.199505 — Posted: 2020-07-13
Tobacco, but not nicotine and flavor-less electronic cigarettes, induces ACE2 and immune dysregulation
Lee, A. C., Chakladar, J., Li, W. T., Chen, C., Chang, E. Y., Wang-Rodriguez, J., Ongkeko, W. M.
10.1101/2020.07.13.198630 — Posted: 2020-07-13
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses
Hoepel, W., Chen, H.-J., Allahverdiyeva, S., Manz, X., Aman, J., Bonta, P., Brouwer, P., de Taeye, S., Caniels, T., van der Straten, K., Golebski, K., Griffith, G., Jonkers, R., Larsen, M., Linty, F., Neele, A., Nouta, J., van Baarle, F., van Drunen, C., Vlaar, A., de Bree, G., Sanders, R., Willemsen, L., Wuhrer, M., Bogaard, H. J., van Gils, M., Vidarsson, G., de Winther, M. P. J., den Dunnen, J.
10.1101/2020.07.13.190140 — Posted: 2020-07-13 Discussion: Onsite | Offsite
Cold sensitivity of the SARS-CoV-2 spike ectodomain
Edwards, R. J., Mansouri, K., Stalls, V., Manne, K., Watts, B., Parks, R., Gobeil, S. M. C., Janowska, K., Li, D., Lu, X., Deyton, M., Sprenz, J., Williams, W., Saunders, K., Sempowski, G. D., Henderson, R., Alam, M., Haynes, B. F., Acharya, P.
10.1101/2020.07.12.199588 — Posted: 2020-07-13
Empirical non-linear modeling & forecast of global daily deaths of COVID-19 pandemic & evidence that a third wave is beginning to decay
Sanchez-Sesma, J.
10.1101/2020.07.07.20147900 — Posted: 2020-07-13
Flexibility and mobility of SARS-CoV-2-related protein structures
Rudolf A Roemer, Navodya Sophie Roemer, Anne Katrine Wallis
10.1101/2020.07.12.199364 — Posted: 2020-07-12
Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro
Geoffrey Dow, Angela Luttick, Jen Fenner, David Wesche, Karen Rowland Yeo, Craid Rayner
10.1101/2020.07.12.199059 — Posted: 2020-07-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).